The effect of some acrylic polymers on dissolution of celecoxib solid dispersion formulations

References

• Alonzo DE, Zhang GGZ, Zhou D, Gao Y, Taylor LS. 2010. Understanding the behavior of amorphous pharmaceutical systems during dissolution. Pharm Res. 27(4):608–618.
   PubMed Web of Science ®Google Scholar
• Andrews GP, Abu-Diak O, Kusmanto F, Hornsby P, Hui Z, Jones DS. 2010. Physicochemical characterization and drug-release properties of celecoxib hot-melt extruded glass solutions. J Pharm Pharmacol. 62(11):1580–1590.
   PubMed Web of Science ®Google Scholar
• Babu NJ, Nangia A. 2011. Solubility advantage of amorphous drugs and pharmaceutical cocrystals. Cryst Growth Des. 11(7):2662–2679.
   Web of Science ®Google Scholar
• Baird JA, Taylor LS. 2012. Evaluation of amorphous solid dispersion properties using thermal analysis techniques. Adv Drug Deliv Rev. 64(5):396–421.
   PubMed Web of Science ®Google Scholar
• Brouwers J, Brewster ME, Augustijns P. 2009. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? J Pharm Sci. 98(8):2549–2572.
   PubMed Web of Science ®Google Scholar
• Chawla G, Gupta P, Thilagavathi R, Chakraborti AK, Bansal AK. 2003. Characterization of solid-state forms of celecoxib. Eur J Pharm Sci. 20(3):305–317.
   PubMed Web of Science ®Google Scholar
• Cilurzo F, Minghetti P, Selmin F, Casiraghi A, Montanari L. 2003. Polymethacrylate salts as new low-swellable mucoadhesive materials. J Controll Release. 88(1):43–53.
   PubMed Web of Science ®Google Scholar
• Dahan A, Miller JM. 2012. The solubility-permeability interplay and its implications in formulation design and development for poorly soluble drugs. AAPS J. 14(2):244–251.
   PubMed Web of Science ®Google Scholar
• Fouad EA, El-Badry M, Mahrous GM, Alanazi FK, Neau SH, Alsarra IA. 2011. The use of spray-drying to enhance celecoxib solubility. Drug Dev Ind Pharm. 37(12):1463–1472.
   PubMed Web of Science ®Google Scholar
• Frank DS, Matzger AJ. 2019. Effect of polymer hydrophobicity on the stability of amorphous solid dispersions and supersaturated solutions of a hydrophobic pharmaceutical. Mol Pharm. 16(2):682–688.
   PubMedGoogle Scholar
• Gao P, Guyton ME, Huang T, Bauer JM, Stefanski KJ, Lu Q. 2004. Enhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturatable formulations. Drug Dev Ind Pharm. 30(2):221–229.
   PubMed Web of Science ®Google Scholar
• Gupta P, Kakumanu VK, Bansal AK. 2004. Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective. Pharm Res. 21(10):1762–1769.
   PubMed Web of Science ®Google Scholar
• Gupta P, Thilagavathi R, Chakraborti AK, Bansal AK. 2005. Role of molecular interaction in stability of celecoxib-PVP amorphous systems. Mol Pharm. 2(5):384–391.
   PubMedGoogle Scholar
• Homayouni A, Sadeghi F, Nokhodchi A, Varshosaz J, Garekani HA. 2014. Preparation and characterization of celecoxib solid dispersions; comparison of poloxamer-188 and PVP-K30 as carriers. Iran J Basic Med Sci. 17(5):322–331.
   PubMed Web of Science ®Google Scholar
• Homayouni A, Sadeghi F, Nokhodchi A, Varshosaz J, Garekani HA. 2015. Preparation and characterization of celecoxib dispersions in Soluplus®: comparison of spray drying and conventional methods. Iran J Pharm Res. 14(1):35–50.
   PubMed Web of Science ®Google Scholar
• Homayouni A, Sadeghi F, Varshosaz J, Garekani HA, Nokhodchi A. 2014. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP. Eur J Pharm Biopharm. 88(1):261–274.
   PubMed Web of Science ®Google Scholar
• Hsieh YL, Box K, Taylor LS. 2014. Assessing the impact of polymers on the pH-induced precipitation behavior of poorly water soluble compounds using synchrotron wide angle X-ray scattering . J Pharm Sci. 103(9):2724–2735.
   PubMed Web of Science ®Google Scholar
• Ilevbare GA, Liu H, Edgar KJ, Taylor LS. 2013. Maintaining supersaturation in aqueous drug solutions: impact of different polymers on induction times. Cryst Growth Des. 13(2):740–751.
   Web of Science ®Google Scholar
• Janssens S, Van den Mooter G. 2009. Review: physical chemistry of solid dispersions. J Pharm Pharmacol. 61(12):1571–1586.
   PubMed Web of Science ®Google Scholar
• Kiew TY, Cheow WS, Hadinoto K. 2015. Preserving the supersaturation generation capability of amorphous drug-polysaccharide nanoparticle complex after freeze drying. Int J Pharm. 484(1–2):115–123.
   PubMedGoogle Scholar
• Lam M, Ghafourian T, Nokhodchi A. 2019. Liqui-pellet: the emerging next-generation oral dosage form which stems from liquisolid concept in combination with pelletization technology. AAPS PharmSciTech. 20(6):231.
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim MJ, Yoon H, Shim CR, Ko HA, Cho SA, Lee D, Khang G. 2013. Enhanced dissolution rate of celecoxib using PVP and/or HPMC-based solid dispersions prepared by spray drying method. J Pharm Investig. 43(3):205–213.
   Google Scholar
• Lin-Vien D, Colthup NB, Fateley WG, Grasselli JG. 1991. The handbook of infrared and Raman characteristic frequencies of organic molecules. San-Diego: Academic Press.
   Google Scholar
• Maghsoodi M, Nokhodchi A, Azhdarzadeh Oskuei M, Heidari S. 2019. Formulation of cinnarizine for stabilization of its physiologically generated supersaturation. AAPS PharmSciTech. 20(3):139.
   PubMed Web of Science ®Google Scholar
• Maghsoodi M, Nokhodchi A, Babi HI. 2020. Rational selection of formulation components to improve dissolution of Dipyridamole. J Drug Deliv Sci Technol. 55:101467. doi.org/10.1016/j.jddst.2019.101467.
   Web of Science ®Google Scholar
• Matsushita T, Fecht HJ, Wunderlich RK, Egry I, Seetharaman S. 2009. Studies of the thermophysical properties of commercial CMSX-4 alloy. J Chem Eng Data. 54(9):2584–2592.
   Web of Science ®Google Scholar
• Morgen M, Bloom C, Beyerinck R, Bello A, Song W, Wilkinson K, Steenwyk R, Shamblin S. 2012. Polymeric nanoparticles for increased oral bioavailability and rapid absorption using celecoxib as a model of a low-solubility, high-permeability drug. Pharm Res. 29(2):427–440.
   PubMed Web of Science ®Google Scholar
• Mosquera-Giraldo LI, Borca CH, Parker AS, Dong Y, Edgar KJ, Beaudoin SP, Slipchenko LV, Taylor LS. 2018. Crystallization inhibition properties of cellulose esters and ethers for a group of chemically diverse drugs: experimental and computational insight. Biomacromolecules. 19(12):4593–4606.
   PubMed Web of Science ®Google Scholar
• Moustafine RI, Margulis EB, Sibgatullina LF, Kemenova VA, Mooter GV. 2008. Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit® L100 and Eudragit® L100-55 as potential carriers for oral controlled drug delivery. Eur J Pharm Biopharm. 70(1):215–225.
   PubMed Web of Science ®Google Scholar
• Moustafine RI, Zaharov IM, Kemenova VA. 2006. Physicochemical characterization and drug release properties of Eudragit E PO/Eudragit L 100-55 interpolyelectrolyte complexes . Eur J Pharm Biopharm. 63(1):26–36.
   PubMed Web of Science ®Google Scholar
• Paradkar AR, Chauhan B, Yamamura S, Pawar AP. 2003. Preparation and characterization of glassy celecoxib. Drug Dev Ind Pharm. 29(7):739–744.
   PubMed Web of Science ®Google Scholar
• Raina SA, Alonzo DE, Zhang GGZ, Gao Y, Taylor LS. 2014. Impact of polymers on the crystallization and phase transition kinetics of amorphous nifedipine during dissolution in aqueous media. Mol Pharm. 11(10):3565–3576.
   PubMedGoogle Scholar
• Raina SA, Zhang GGZ, Alonzo DE, Wu J, Zhu D, Catron ND, Gao Y, Taylor LS. 2014. Enhancements and limits in drug membrane transport using supersaturated solutions of poorly water soluble drugs. J Pharm Sci. 103(9):2736–2748.
   PubMed Web of Science ®Google Scholar
• Shono Y, Jantratid E, Janssen N, Kesisoglou F, Mao Y, Vertzoni M, Reppas C, Dressman JB. 2009. Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling. Eur J Pharm Biopharm. 73(1):107–114.
   PubMed Web of Science ®Google Scholar
• Thakral S, Thakral NK, Majumdar DK. 2013. Eudragit®: a technology evaluation. Expert Opin Drug Deliv. 10(1):131–149.
   PubMed Web of Science ®Google Scholar
• Warren DB, Benameur H, Porter CJH, Pouton CW. 2010. Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: a mechanistic basis for utility. J Drug Target. 18(10):704–731.
   PubMed Web of Science ®Google Scholar
• Williams HD, Trevaskis NL, Charman SA, Shanker RM, Charman WN, Pouton CW, Porter CJH. 2013. Strategies to address low drug solubility in discovery and development. Pharmacol Rev. 65(1):315–499.
   PubMed Web of Science ®Google Scholar
• Xie T, Taylor LS. 2016. Dissolution performance of high drug loading celecoxib amorphous solid dispersions formulated with polymer combinations. Pharm Res. 33(3):739–750.
   PubMed Web of Science ®Google Scholar
• Yokoi Y, Yonemochi E, Terada K. 2005. Effects of sugar ester and hydroxypropyl methylcellulose on the physicochemical stability of amorphous cefditoren pivoxil in aqueous suspension. Int J Pharm. 290(1–2):91–99.
   PubMedGoogle Scholar
• Yoo S, Krill SL, Wang Z, Telang C. 2009. Miscibility/stability considerations in binary solid dispersion systems composed of functional excipients towards the design of multi-component amorphous systems. J Pharm Sci. 98(12):4711–4723.
   PubMed Web of Science ®Google Scholar
• Yoshida T, Kurimoto I, Umejima H, Watanabe S, Sako K, Kikuchi A. 2013. Effects of dissolved state of aminoalkyl methacrylate copolymer E/HCl on solubility enhancement effect for poorly water-soluble drugs. Colloid Polym Sci. 291(5):1191–1199.
   Web of Science ®Google Scholar
• Yoshida T, Kurimoto I, Yoshihara K, Umejima H, Ito N, Watanabe S, Sako K, Kikuchi A. 2012. Aminoalkyl methacrylate copolymers for improving the solubility of tacrolimus. I: evaluation of solid dispersion formulations. Int J Pharm. 428(1–2):18–24.
   PubMedGoogle Scholar
• Zimmermann A, Millqvist-Fureby A, Elema MR, Hansen T, Müllertz A, Hovgaard L. 2009. Adsorption of pharmaceutical excipients onto microcrystals of siramesine hydrochloride: effects on physicochemical properties. Eur J Pharm Biopharm. 71(1):109–116.
   PubMed Web of Science ®Google Scholar